| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |